FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products

May.06
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.

Key Takeaways

  • FDA authorized four Glas ENDS products for legal marketing in the U.S. to adults aged 21 and older.
  • The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods.
  • Each pod contains 50mg/ml, or 5%, tobacco-derived nicotine.
  • FDA said this is its first authorization of non-tobacco and non-menthol ENDS products.
  • The products use age and identity verification, smartphone pairing and random biometric check-ins to restrict youth access.

2Firsts, May 6, 2026 

 

According to the U.S. Food and Drug Administration, the agency authorized the marketing of four Glas electronic nicotine delivery system products through the premarket tobacco product application pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.

 

FDA authorized its first non-tobacco and non-menthol ENDS products

 

The FDA said the action marks its first authorization of non-tobacco and non-menthol ENDS products. The agency said the authorization permits only these four specific Glas products to be legally marketed in the U.S. to adults aged 21 and older and does not apply to any other Glas products.

 

Agency cited device access restrictions and marketing controls

 

The FDA said its scientific review found that Glas’s device access restriction technology, combined with FDA-required marketing restrictions, is expected to effectively reduce the ability of youth to use the product.

 

Device requires government ID and smartphone pairing

 

According to the FDA, the technology requires users to verify their age and identity using a government-issued ID and pair the device with a smartphone via Bluetooth. After verification, the device will not operate if separated from the phone.

 

The FDA said the app also conducts random biometric check-ins to periodically confirm that the registered user is the person using the device.

 

Adults completed verification while youth could not use the product

 

The agency said the applicant showed that most adults aged 21 and older successfully completed age verification and found the device instructions and age-verification software easy to understand and activate, while youth and young adults could not.

 

FDA said authorization shows one route for flavored products to meet public health standard

 

The FDA said the orders confirm the availability of an additional way for demonstrating that a non-tobacco flavored product can meet the public health standard by using effective age-gating. 

 

The agency said a non-tobacco flavored product may be authorized when an application demonstrates that its benefit in helping adults quit cigarette smoking outweighs potential risks.

 

Marketing must target adults 21 and older

 

To further reduce potential youth use by limiting youth exposure to advertising, marketing and promotion, the FDA said the marketing orders require the company to ensure its advertising is carefully targeted to adults aged 21 and older.

 

The FDA said Glas must track, measure and report to the agency the effectiveness of its youth-prevention measures. 

 

The company must also provide analyses of the demographics of audiences reached by its advertising, marketing and promotional activities.

 

FDA may suspend or withdraw authorization

 

The FDA said it will closely monitor how the products are marketed and may act if the company fails to comply with statutory or regulatory requirements. 

 

The agency may suspend or withdraw authorization if continued marketing is no longer appropriate for the protection of public health, including if youth use notably increases or if evidence shows that product benefits no longer outweigh risks.

 

FDA says 45 ENDS products are now authorized in the U.S.

 

With the new marketing orders, the FDA said it has now authorized 45 ENDS products for marketing in the U.S. The agency said these 45 products are the only ENDS products currently allowed to be lawfully sold in the United States.

 

The FDA said it continues to take actions against unauthorized ENDS products that remain illegally on the market, including initiatives to help retailers comply with relevant laws and regulations and joint enforcement operations with federal partners at borders and ports.

 

Image Source:FDA


GLAS PMTA Special report:

 

FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Technology reported financial results on May 7, 2026, for the third quarter of fiscal 2026, covering the three months ended March 31, 2026. Revenue was $18.7 million, compared with $26.2 million in the third quarter of fiscal 2025 and $20.3 million in the prior quarter. Gross profit was $2.0 million, with gross margin of 10.7%. Net loss was $9.5 million, or $0.17 per share. The company said it held $18.0 million in cash as of March 31, 2026, up $468,000 sequentially.
May.08 by 2FIRSTS.ai
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
The U.S. Food and Drug Administration announced on May 6 that it has advanced its modernization initiative by launching Elsa 4.0, an upgraded internal AI tool, and consolidating more than 40 application and submission data sources, systems and portals into a new platform called HALO. FDA said the integration of HALO and Elsa will allow staff to query data and build workflows without manually uploading documents in each chat.
May.07 by 2FIRSTS.ai
Philip Morris Korea Names Lee Hong-seok as New CEO Effective May 1
Philip Morris Korea Names Lee Hong-seok as New CEO Effective May 1
Philip Morris Korea said on April 29 that it has appointed Lee Hong-seok, head of its smoke-free products division, as its new chief executive officer, with his term beginning on May 1. Yoon Hee-kyung, who took office in 2023, will step down after about three years in the role.
Apr.30 by 2FIRSTS.ai
Charlie’s Plans Q3 2026 Pilot of America’s First Age-Gated Flavored Disposable Vape
Charlie’s Plans Q3 2026 Pilot of America’s First Age-Gated Flavored Disposable Vape
U.S. vape company Charlie’s Holdings announced plans to pilot its age-gated flavored disposable vape products in hundreds of retail stores during the third quarter of 2026. The company said the products will utilize AI- and blockchain-powered age-verification technology designed to address FDA concerns over youth access and potentially create a new compliance pathway for flavored vape products.
Jun.15
Illicit Vape and Nicotine Pouch Seizures Concentrated in UK Hotspots, New Data Shows
Illicit Vape and Nicotine Pouch Seizures Concentrated in UK Hotspots, New Data Shows
Freedom of Information (FOI) data from the UK shows that more than 3,000 seizures of illegal nicotine products were recorded in the 2024/25 financial year, with Hull, Liverpool and Bolton emerging as the most active enforcement hotspots — highlighting that the problem of illicit vapes, nicotine pouches and smokeless tobacco products persists across many parts of the country.
Jun.16